Mechanisms of Progression From Thrombosis to Fibrosis

Fogo, Agnes B.

Abstract

Funding Agency

• Agency: National Institute of Health (NIH)
• Institute: National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
• Type: Research Project (R01)
• Project #: 1R01DK052104-01
• Application #: 2017647
• Study Section: Special Emphasis Panel (SRC (01))
• Project Start: 1996-09-30
• Project End: 1999-08-31
• Budget Start: 1996-09-30
• Budget End: 1997-08-31
• Support Year: 1
• Fiscal Year: 1996

Institution

• Name: Vanderbilt University Medical Center
• Department: Pathology
• Type: Schools of Medicine
• DUNS #: 004413456
• City: Nashville
• State: TN
• Country: United States
• Zip Code: 37212

Publications

Ma, L J; Marcantoni, C; Linton, M F et al. (2001) Peroxisome proliferator-activated receptor-gamma agonist troglitazone protects against nondiabetic glomerulosclerosis in rats. Kidney Int 59:1899-910

Ma, L J; Nakamura, S; Whitsitt, J S et al. (2000) Regression of sclerosis in aging by an angiotensin inhibition-induced decrease in PAI-1. Kidney Int 58:2425-36

Johnson, R J; Kivlighn, S D; Kim, Y G et al. (1999) Reappraisal of the pathogenesis and consequences of hyperuricemia in hypertension, cardiovascular disease, and renal disease. Am J Kidney Dis 33:225-34